Literature DB >> 12631413

Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.

Miao-Ying Lai1, Su-Lan Hsiu, Shang-Yuan Tsai, Yu-Chi Hou, Pei-Dawn Lee Chao.   

Abstract

Baicalin and baicalein, a flavone glucuronide and its aglycone, are bioactive constituents of Scutellariae Radix with various beneficial activities. We have characterized and compared the metabolic pharmacokinetics of baicalin and baicalein in rats. Baicalein was administered intravenously and orally to rats, and baicalin was orally administered. An HPLC method was used to determine the concentration of baicalein before and after hydrolysis using beta-glucuronidase/sulfatase. The pharmacokinetic parameters were calculated by using WINNONLIN. Unpaired Student's t-test was used for statistical comparison. The result showed that after intravenous administration of baicalein, 75.7% of the dose was circulating as its conjugated metabolites. After oral administration of baicalein, absorption of baicalein itself was negligible, whereas the glucuronides/sulfates of baicalein were predominant in the plasma. When compared with intravenous bolus administration with dose correction, the absolute absorption was 40%. When baicalin was administered orally, glucuronides and sulfates of baicalein were exclusively circulating in the plasma. The relative absorption for baicalin was 65% when compared with baicalein. Profound differences of serum profile and pharmacokinetics were observed between oral baicalein and baicalin. Baicalin demonstrated significantly later time to peak concentration (t(max)) and lower peak serum concentration (C(max)) of baicalein conjugated metabolites than baicalein, indicating baicalin was absorbed more slowly and to a lesser extent than baicalein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631413     DOI: 10.1211/002235702522

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  42 in total

1.  Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.

Authors:  Xiuqiong He; Lixia Pei; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Role of intestinal first-pass metabolism of baicalein in its absorption process.

Authors:  Li Zhang; Ge Lin; Qi Chang; Zhong Zuo
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

3.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.

Authors:  Pamela Maher
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

Review 4.  Botanical flavonoids on coronary heart disease.

Authors:  Chong-Zhi Wang; Sangeeta R Mehendale; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2011       Impact factor: 4.667

Review 5.  Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.

Authors:  Haijun Chen; Yu Gao; Jianlei Wu; Yingyu Chen; Buyuan Chen; Jianda Hu; Jia Zhou
Journal:  Cancer Lett       Date:  2014-08-13       Impact factor: 8.679

6.  Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.

Authors:  J M Huang; W Y Weng; X B Huang; Y H Ji; E Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

7.  Hepatic metabolism and disposition of baicalein via the coupling of conjugation enzymes and transporters-in vitro and in vivo evidences.

Authors:  Li Zhang; Chenrui Li; Ge Lin; Peter Krajcsi; Zhong Zuo
Journal:  AAPS J       Date:  2011-05-24       Impact factor: 4.009

8.  Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.

Authors:  Chieh-Yu Peng; Shiow-Lin Pan; Ying-Wen Huang; Jih-Hwa Guh; Ya-Ling Chang; Che-Ming Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

9.  Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.

Authors:  Yilan Zhang; Rui Luo; Yi Chen; Xue Ke; Danrong Hu; Miaomiao Han
Journal:  AAPS PharmSciTech       Date:  2014-02-26       Impact factor: 3.246

10.  Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response.

Authors:  Chongshan Dai; Shusheng Tang; Yang Wang; Tony Velkov; Xilong Xiao
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.